[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356452-105":59,"doc-detail-356452-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","phosphorylations-of-serines-219-in-glycogen-synthase-kinase-3-are-dispensable-for-v600ebraf-driven-premalignant-tumour-development-in-the-mouse-intestine","Phosphorylations of serines 21/9 in glycogen synthase kinase 3α/β are dispensable for V600EBRAF-driven premalignant tumour development in the mouse intestine","","Valine-to-glutamate substitution at residue 600 of BRAF (V600EBRAF mutation) is common in human colorectal cancers with serrated histopathology and is considered a founder event. Prior conditional knock-in mouse work showed that V600EBraf induces short-term crypt hyperplasia and long-term reduced survival linked to increased tumour burden, with E2F targets, MYC signalling, G2/M transition, canonical Wnt signalling and cholesterol biosynthesis signatures. Here, homozygous Gsk3αβS9A/S21A knock-in on the V600EBraf background reveals only a marginal short-term effect, lost long-term with no differences in survival, tumour burden or grade, and minimal transcriptional changes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/phosphorylations-of-serines-219-in-glycogen-synthase-kinase-3-are-dispensable-for-v600ebraf-driven-premalignant-tumour-development-in-the-mouse-intestine/356452/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/phosphorylations-of-serines-219-in-glycogen-synthase-kinase-3-are-dispensable-for-v600ebraf-driven-premalignant-tumour-development-in-the-mouse-intestine/356452.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What mutation and model are used to study colorectal tumour development?","Question",{"text":112,"@type":113},"The study focuses on the V600EBRAF mutation using a conditional knock-in mouse model to model premalignant tumour development in the mouse intestine.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does GSK3αβ phosphorylation at serines 21/9 affect crypt hyperplasia and long-term outcomes?",{"text":117,"@type":113},"Introducing Gsk3αβS9A/S21A mutations on the V600EBraf background produces only a marginal increase in crypt proliferation short-term, but the effect is lost long-term, with no significant differences in survival, tumour burden, or tumour grade.",{"name":119,"@type":110,"acceptedAnswer":120},"What signalling-related gene programs change after V600EBraf expression, and are they altered by Gsk3αβ knock-in?",{"text":121,"@type":113},"V600EBraf induces gene signatures related to E2F targets, MYC signalling, G2/M transition, canonical Wnt signalling, and cholesterol biosynthesis. These transcriptional programs are largely reverted or unchanged by Gsk3αβ knock-in, except for three genes whose expression is significantly altered.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356452,1790307120,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","OPEN ACCESS  \nCitation: Farahmand P, Rzasa P, Green C, Hey F, Giblett S, Jin H, et al. (2026) Phosphorylationsof serines 21/9 in glycogen synthase kinase 3α/β are dispensable for V600EBRAF-driven premalignant tumour development in the mouse intestine. PLoS One 21(3): e0337259 .  \n[https://doi.org/10.1371/journal.pone.0337259](https://doi.org/10.1371/journal.pone.0337259)  \nEditor: Divijendra Natha Reddy Sirigiri, BMSCE: BMS College of Engineering, INDIA  \nReceived: September 5, 2024  \nAccepted: November 4, 2025  \nPublished: March 6, 2026  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0337259  \nCopyright: © 2026 Farahmand et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  \nRESEARCH ARTICLE  \nPhosphorylations of serines 21/9 in glycogen synthase kinase 3α/β are dispensable for V600EBRAF-driven premalignant tumour development in the mouse intestine  \nPooyeh Farahmand1¤, Paulina Rzasa1, Caleb Green1, Fiona Hey1, Susan Giblett1,  \nHong Jin1, Kevin West2, Nicolas B. Sylvius3, Catrin A. Pritchard1*, Alessandro Rufini1,4*  \n1 Leicester Cancer Research Centre, University of Leicester, Clinical Sciences Building, Leicester, United Kingdom, 2 Department of Cellular Pathology, University Hospitals of Leicester, Leicester, United Kingdom, 3 NUCLEUS Genomics, Core Biotechnology Services, University of Leicester, Leicester, United Kingdom, 4 Dipartimento di Bioscience, University of Milan, Milan, Italy  \n¤ Current address: University of Glasgow/Cancer Research UK Scotland Institute, Glasgow, UK  \n* [cap8@le.ac.uk](cap8@le.ac.uk) (CAP), [alessandro.rufini@unimi.it](alessandro.rufini@unimi.it) (AR)  \nAbstract  \nValine to glutamate substitution at residue 600 of the BRAF oncogene (V600EBRAF mutation) is prevalent in human colorectal cancers with a serrated histopathology and is thought to be a founder mutation. Using a conditional knock-in mouse model we have previously demonstrated that V600EBraf drives crypt hyperplasia in the short term as well as shortened survival linked to increased tumour burden in the long-term. These phenotypes are associated with induction of gene signatures for E2F targets, MYC signalling, G2/M transition, canonical Wnt signalling, and cholesterol biosynthesis. Although these gene signatures are reverted by MEK inhibition, there remains a lack of understanding of the signalling pathways involved, particularly the mechanism of crosstalk between the MAPK and Wnt pathways. Here, we have examined a role for phosphorylation of GSK3αβ isoforms at residues S21/S9 . By introducing homozygous knock-in mutations for Gsk3αβS9A/S21A onto the V600EBraf background, we unexpectedly show a marginal effect of these mutations on further increasing crypt proliferation. However, this impact is lost in the long-term as there are no significant differences in mouse survival, tumour burden or tumour grade. Consistently, the Gsk3αβ knock-in mutations do not change the transcriptional programme induced by V600EBraf, except for 3 genes (Ephx4 , Eif2b3 Ppp1r13l) whose expression is significantly altered, potentially contributing to the short-term increase in crypt hyperplasia. Overall, our data show that therapeutic strategies targeting GSK3αβ phosphorylation at serines 21/9 are not worthwhile options for V600EBRAF colorectal cancers.  \nPLOS One | [https://doi.org/10.1371/journal.pone.0337259](https://doi.org/10.1371/journal.pone.0337259) March 6, 2026 1 / 17  \nand reproduction in any medium, provided the original author and source are credited.  \nData availability statement: All microarray data files are available from the GEO datab","cbCaioyo6VIa952V","https://ap.wps.com/l/cbCaioyo6VIa952V","pdf",1658395,17,"English","# Abstract\n## Introduction","[{\"question\":\"What mutation and model are used to study colorectal tumour development?\",\"answer\":\"The study focuses on the V600EBRAF mutation using a conditional knock-in mouse model to model premalignant tumour development in the mouse intestine.\"},{\"question\":\"How does GSK3αβ phosphorylation at serines 21/9 affect crypt hyperplasia and long-term outcomes?\",\"answer\":\"Introducing Gsk3αβS9A/S21A mutations on the V600EBraf background produces only a marginal increase in crypt proliferation short-term, but the effect is lost long-term, with no significant differences in survival, tumour burden, or tumour grade.\"},{\"question\":\"What signalling-related gene programs change after V600EBraf expression, and are they altered by Gsk3αβ knock-in?\",\"answer\":\"V600EBraf induces gene signatures related to E2F targets, MYC signalling, G2/M transition, canonical Wnt signalling, and cholesterol biosynthesis. These transcriptional programs are largely reverted or unchanged by Gsk3αβ knock-in, except for three genes whose expression is significantly altered.\"}]","Phosphorylations of serines 21/9 in glycogen synthase kinase 3α/β are dispensable for V600EBRAF-driven premalignant tumour development in the mouse intestine | PDF",1790125378,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d651e85ead992fe79f68f2b665efde0.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f10c79eab2353124165a644fae05963b.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9de98a4d1a7fab4f296e21fa67adedd9.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8bc348ab247893038b5708b18ffe9c56.webp",980,1268]